At a glance
ClinicalIndex Comparison RecordN/ACompleted· 4,774 enrolled
Drug / intervention
Active choice +1 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Pragmatic, Randomized Evaluation of Statin Active Choice to Reach Improved Outcomes Based on Evidence
In Brief
A clinical study evaluating Active choice and Social comparison feedback for Cardiovascular Diseases. Completed, enrolled 4,774 participants across 1 site.
Detailed Summary
In this study, the investigators will conduct a pragmatic, cluster-randomized, controlled trial to evaluate an active choice intervention with and without social comparison feedback to increase physician statin prescribing rates for eligible patients.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCardiovascular Diseases
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedJan 2017
Enrollment StartFeb 2017
Primary CompletionApr 2017
TodayJul 2026
First PostedJan 16, 2017
Enrollment StartFeb 21, 2017
Primary CompletionApr 21, 2017
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 9.5 years ago
Interventions
Active choicebehavioral
Statin options are framed to physicians as an active choice to prescribe or not prescribe a statin
Social comparison feedbackbehavioral
Statin prescribing rates are communicated to physicians and along with how their performance compares to their peers